@article{0158a84a6a9d445997b9247f5902e273,
title = "Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France",
keywords = "Cost-effectiveness, Economic evaluation, Osteoporosis, Risedronate, Treatment, QUALITY-OF-LIFE, ECONOMIC-EVALUATION, INTERVENTION THRESHOLDS, ORAL BISPHOSPHONATES, EXCESS MORTALITY, HIP FRACTURE, PERSISTENCE, ADHERENCE, HOSPITALIZATION, BURDEN",
author = "M. Hiligsmann and Reginster, {J. -Y.}",
year = "2019",
month = mar,
doi = "10.1007/s00198-018-04821-7",
language = "English",
volume = "30",
pages = "649--658",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer-Verlag London Ltd.",
number = "3",
}